drugset / Trial / NCT00862303
DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating Patients With Renal Cell Carcinoma
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to show if vaccination with autologous dendritic cells pulsed with tumor lysate in combination with Cytokine-Induced Killer Cell (CIK) can induce a measurable immune response in patients with renal cell carcinoma, and to evaluate the clinical effect of the regimen.
Timeline
- Start
- 2009-03
- Primary completion
- 2015-06
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CIK cells | Cell therapy | — | — |
| Subject | DC vaccine | Vaccine | — | Other |
| Comparator | IFN-α | Unknown | — | — |
| Comparator | aldesleukin | Protein / enzyme biologic | — | — |